We are a team of biomedical scientists, engineers, and data scientists striving to provide innovative and robust solutions to complex scientific challenges.
sciKāl provide services and products under three verticals: 1) phenotypic drug screening, 2) data analytics, and 3) technology development.
Our technological solutions are supported by the Biotechnology Industry Research Advisory Council (BIRAC, Govt. of India) and also published in internationally reputed peer-reviewed scientific journals.
Using our proprietary phenotypic drug screening platform, we have reduced the cost and duration of canonical in-vivo screening by order of magnitude, along with increasing the probability of technical success of lead molecules.
Our data analytics and technology development platform works hand in hand with our partners and clients to provide innovative tailor-made solutions specific to their requirements.
Company Details
- Employees
- 1
- Founded
- 2022
- Address
- Centre For Cellular And Molecular Platforms (C-Camp), National Centre For Biological Sciences (Ncbs),india
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://scikal.com/
- Keywords
- Drug Discovery, Data Analytics, Technology Development, Degenerative Disorders, Rare Disorders, Precision Medicine.
- HQ
- Bengaluru, Karnataka
Scikāl Questions
Scikāl's website is https://scikal.com/
Scikāl's LinkedIn profile is https://in.linkedin.com/company/scikal
Scikāl has
1 employees.
View email and phone details for 1
employees at Scikāl.
Scikāl's industry is
Biotechnology Research
Scikāl's top competitors are
Nanoworld,
Lifesci Connect,
Cellworks Research India Private Limited,
Biokal,
Qiagen Wrocław,
Genophe Biotech Pvt Ltd,
Growth Xpert,
Karewise.com,
Climatecrop Ltd.,
Scientific Bio-Minds.
Scikāl's categories are Biotechnology Research
Scikāl's founding year is 2022
